EEP — Euroespes SA Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -48.13% | ||
Return on Equity | -22.57% | ||
Operating Margin | -42.83% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 2.37 | 2.52 | 3.29 | 3.3 | 2.95 | n/a | n/a | 2.99% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Euroespes SA is a Spain-based company engaged in the healthcare sector. The Company operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Company’s medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The Company operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.
Directors
- Ramon Cacabelos Garcia CHM
- Jose Antonio Rodriguez Romero EDR
- Jose Antonio Carrizosa Valverde DRC
- Valentin Diez Llorente DRC
- Juan Carlos Escuris Villa DRC
- Juan Fernandez de Sanmamed Sampedro DRC
- Vicente Lopez-Perea Lloveres DRC
- Pilar Paz Delgado DRC
- Angel Riesgo Alcalde DRC
- Pablo Alvarez de Linera Granda IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2022
- Incorporated
- January 1st, 1970
- Public Since
- June 21st, 2012
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Madrid Stock Exchange
- Shares in Issue
- 11,509,506

- Address
- Santa Marta de Babio S/N, BERGONDO, 15165
- Web
- https://euroespes.com/
- Phone
- +34 981780505
- Auditors
- Auditoria Y Diagnostico Empresarial, SA
Similar to EEP
Atrys Health SA
Madrid Stock Exchange
Clinica Baviera SA
Madrid Stock Exchange
FAQ
As of Today at 20:30 UTC, shares in Euroespes SA are trading at €0.34. This share price information is delayed by 15 minutes.
Shares in Euroespes SA last closed at €0.34 and the price had moved by -37.04% over the past 365 days. In terms of relative price strength the Euroespes SA share price has underperformed the FTSE Global All Cap Index by -38.61% over the past year.
There is no consensus recommendation for this security.
Find out moreEuroespes SA does not currently pay a dividend.
Euroespes SA does not currently pay a dividend.
Euroespes SA does not currently pay a dividend.
To buy shares in Euroespes SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.34, shares in Euroespes SA had a market capitalisation of .
Here are the trading details for Euroespes SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: EEP
Based on an overall assessment of its quality, value and momentum Euroespes SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Euroespes SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -1.29%.
As of the last closing price of €0.34, shares in Euroespes SA were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Euroespes SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Euroespes SA's management team is headed by:
- Ramon Cacabelos Garcia - CHM
- Jose Antonio Rodriguez Romero - EDR
- Jose Antonio Carrizosa Valverde - DRC
- Valentin Diez Llorente - DRC
- Juan Carlos Escuris Villa - DRC
- Juan Fernandez de Sanmamed Sampedro - DRC
- Vicente Lopez-Perea Lloveres - DRC
- Pilar Paz Delgado - DRC
- Angel Riesgo Alcalde - DRC
- Pablo Alvarez de Linera Granda - IND